معرفی
Theresa Ermer is a Researcher in the Department of Surgery at Yale School of Medicine, specializing in cardiothoracic surgery and clinical outcomes research. She holds an MD and a Dr. med. (medical research doctorate) from Friedrich-Alexander-Universität Erlangen-Nürnberg. Her work focuses on thoracic oncology, health disparities, immunotherapy, and public health policy. She has validated methodologies for dialysis patient biomarkers and led international clinical studies, including identifying a new risk factor for sudden cardiac death.
Research Interests: Dr. Ermer’s research spans immunotherapy in lung cancer, disparities in lung cancer screening, and socioeconomic factors influencing cancer outcomes. Her work integrates epidemiology with clinical practice to address health equity. Recent efforts include studying Medicaid expansion impacts on cancer care and analyzing FDA approval disparities in immunotherapy access.
Publications Overview: Her 15 most recent articles (2020–2024) highlight interdisciplinary work across oncology, nephrology, and public health. Key themes include optimizing immunotherapy protocols, reducing disparities in cancer care, and understanding dialysis-related risks. Collaborations with institutions like the Stephen & Denise Adams Center for Parkinson’s Disease Research further underscore her translational research approach.
- Awards: Gerda-Weller Prize for doctoral thesis excellence (2021)
Advancing Healthcare: Dr. Ermer’s work bridges clinical practice and population health, advocating for equitable access to treatments through policy analysis and outcomes research. She has contributed to guideline revisions for lung cancer staging and surgical pathways during the pandemic.
